Streamlining and cycle time reduction of the startup phase of clinical trials

OBJECTIVE: The startup phase of a clinical trial (CT) plays a vital role in the execution of new drug development. Hence, the aim of this study is to identify the factors responsible for delaying the CT startup phase. Further, it focuses on streamlining and reducing the cycle time of the startup pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Shaheen, Amani, Al Badr, Ahmad, Al Fayyad, Isamme, Al Qutub, Adel, Faqeih, Eissa Ali, Al-Tannir, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988200/
https://www.ncbi.nlm.nih.gov/pubmed/31996249
http://dx.doi.org/10.1186/s13063-020-4079-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988200/
https://www.ncbi.nlm.nih.gov/pubmed/31996249
http://dx.doi.org/10.1186/s13063-020-4079-8

Ejemplares similares